Par Drugs & Chemicals Ltd

₹ 104 -0.99%

21 May 10:12 a.m.

About

Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals^[1]

Key Points

Business Overview:^[1]
PACL manufactures Active Pharma Ingredients for domestic and exports markets, they have a portfolio of 15 APIs and 10 Fine Chemicals. It produces the entire range of products in the Antacid Molecules segment

Website NSE - BE

Market Cap ₹ 128 Cr.
Current Price ₹ 104
High / Low ₹ 348 / 81.0
Stock P/E 9.58
Book Value ₹ 80.4
Dividend Yield 0.00 %
ROCE 19.5 %
ROE 14.5 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.

Cons

Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	22.08	23.51	24.82	22.93	24.49	22.93	25.89	24.00	22.82	22.61	34.66	21.38	22.33
	17.56	19.81	18.92	19.70	19.10	18.79	18.53	18.77	16.72	18.37	23.25	19.95	19.90
Operating Profit	4.52	3.70	5.90	3.23	5.39	4.14	7.36	5.23	6.10	4.24	11.41	1.43	2.43
OPM %	20.47%	15.74%	23.77%	14.09%	22.01%	18.05%	28.43%	21.79%	26.73%	18.75%	32.92%	6.69%	10.88%
	0.07	0.15	0.02	0.04	0.03	0.01	0.05	0.23	-0.05	0.07	1.02	0.27	0.79
Interest	0.09	0.05	0.03	0.03	0.03	0.02	0.03	0.02	0.05	0.02	0.03	0.01	0.02
Depreciation	0.87	0.73	0.91	0.74	0.85	0.83	0.85	0.87	0.89	0.90	0.91	0.91	0.92
Profit before tax	3.63	3.07	4.98	2.50	4.54	3.30	6.53	4.57	5.11	3.39	11.49	0.78	2.28
Tax %	33.06%	25.08%	25.10%	25.20%	24.01%	25.15%	25.27%	25.16%	27.20%	25.07%	25.15%	24.36%	27.63%
	2.42	2.29	3.73	1.87	3.45	2.47	4.89	3.42	3.72	2.53	8.60	0.58	1.65
EPS in Rs	1.97	1.86	3.03	1.52	2.80	2.01	3.97	2.78	3.02	2.06	6.99	0.47	1.34
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	27	33	33	49	42	46	56	61	75	96	96	101
	20	26	26	40	34	38	46	45	59	78	73	81
Operating Profit	7	7	7	8	8	8	9	16	16	18	23	20
OPM %	27%	22%	22%	17%	19%	18%	17%	26%	22%	19%	24%	19%
	0	0	0	0	0	0	0	2	0	0	0	2
Interest	4	4	4	2	2	2	1	1	0	0	0	0
Depreciation	2	2	3	3	3	3	3	3	3	3	3	4
Profit before tax	1	1	1	3	3	3	6	15	13	15	20	18
Tax %	40%	27%	58%	42%	42%	24%	21%	21%	27%	25%	26%	26%
	1	1	0	2	2	3	5	12	9	11	14	13
EPS in Rs	1.33	1.65	0.78	3.43	2.78	2.79	3.87	9.44	7.49	9.21	11.78	10.86
Dividend Payout %	0%	0%	0%	0%	0%	0%	32%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	12%
5 Years:	13%
3 Years:	10%
TTM:	6%

Compounded Profit Growth
10 Years:	31%
5 Years:	23%
3 Years:	13%
TTM:	-8%

Stock Price CAGR
10 Years:	%
5 Years:	44%
3 Years:	-12%
1 Year:	-58%

Return on Equity
10 Years:	16%
5 Years:	17%
3 Years:	17%
Last Year:	14%

Balance Sheet

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3	3	3	3	3	4	6	6	12	12	12	12
Reserves	8	9	9	11	12	25	34	46	48	59	73	87
	44	38	36	31	29	12	6	8	0	0	0	0
	7	9	10	12	10	11	13	16	19	18	16	20
Total Liabilities	61	59	58	56	54	51	60	76	79	89	102	119
	47	45	43	42	39	36	34	30	34	38	41	39
CWIP	0	0	0	0	0	0	1	5	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	0	0	25
	14	13	15	14	15	15	25	42	44	50	60	55
Total Assets	61	59	58	56	54	51	60	76	79	89	102	119

Cash Flows

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	5	9	7	9	4	2	8	12	8	13	20	16
	-6	-0	-0	-2	-1	-0	-1	0	-3	-7	-6	-25
	2	-9	-5	-8	-4	-2	1	2	-10	0	0	0
Net Cash Flow	1	-1	1	-1	0	-0	7	14	-5	6	14	-9

Ratios

Figures in Rs. Crores

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	104	83	81	61	75	67	81	75	90	65	52	60
Inventory Days	129	111	158	69	83	81	45	50	60	49	45	58
Days Payable	171	184	183	135	107	94	96	112	135	73	58	104
Cash Conversion Cycle	62	10	57	-5	51	55	30	13	14	40	40	15
Working Capital Days	102	61	66	-4	18	47	39	44	61	50	40	39
ROCE %		10%	9%	12%	11%	12%	16%	25%	22%	23%	25%	20%

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	73.37%	73.37%	73.37%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.07%	0.07%	0.32%	0.09%	0.00%	0.00%
	0.12%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.05%	0.00%	0.00%	0.00%	0.00%
	25.68%	25.79%	25.79%	25.79%	25.79%	25.79%	25.73%	25.68%	25.47%	26.54%	26.63%	26.63%
No. of Shareholders	4,262	5,071	5,676	5,585	5,686	5,902	7,020	7,403	8,022	8,757	17,189	15,472

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	73.12%	73.86%	74.21%	74.21%	74.21%	73.37%
	0.00%	0.00%	0.00%	0.00%	0.07%	0.00%
	0.00%	0.00%	0.05%	0.00%	0.05%	0.00%
	26.88%	26.14%	25.75%	25.79%	25.68%	26.63%
No. of Shareholders	400	289	4,034	5,585	7,403	15,472

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Jun 2023

Transcript

Notes
PPT
Jun 2023

Transcript

Notes
PPT
Mar 2023

Transcript

Notes
PPT
Mar 2023

Transcript

Notes
PPT
Feb 2023

Transcript

Notes
PPT
Nov 2022

Transcript

Notes
PPT
Nov 2022

Transcript

Notes
PPT
Aug 2022

Transcript

Notes
PPT
May 2022

Transcript

Notes
PPT
Feb 2022

Transcript

Notes
PPT
Dec 2021

Transcript

Notes
PPT
Nov 2021

Transcript

Notes
PPT
Jun 2021

Transcript

Notes
PPT
Nov 2020

Transcript

Notes
PPT
Nov 2020

Transcript

Notes
PPT
Jun 2020

Transcript

Notes
PPT
Sep 2019

Transcript

Notes
PPT